Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. - Wikidata - awgldk - TriplyDB

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

http://www.wikidata.org/entity/Q35518459

about

Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.Evolutionary and genomic insights into meningococcal biology.Protein-linked glycans in periodontal bacteria: prevalence and role at the immune interface.Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies.Polysaccharide export outer membrane proteins in Gram-negative bacteria.Controlling serogroup B invasive meningococcal disease: the Canadian perspective.The Long Road to an Effective Vaccine for Meningococcus Group B (MenB).Neisseria meningitidis serogroup B bivalent factor H binding protein vaccine.False-Positive Results for Immunoglobulin M Serologic Results: Explanations and Examples.Characterization of the Conjugation Pattern in Large Polysaccharide-Protein Conjugates by NMR Spectroscopy.The β-reducing end in α(2-8)-polysialic acid constitutes a unique structural motif.

P2860

Q28730934-326A0D51-3ED4-47DA-8CE1-D461F5A80F74 Q35989852-F73DFC79-743B-43E2-93D3-611B3771DBFC Q36382175-F9883340-3E84-44E8-9B8A-0DB37CD004C6 Q37232860-29D0DE46-EA45-4883-9873-4ED3CBBE54D7 Q37425396-292B472A-7487-4CC3-8ABB-2B0DCF25914A Q38093649-3345E5D5-A6AD-4EB0-8530-7910EB5A40B0 Q38105338-F835F884-3F4B-4C49-8C8A-8C96257C94F2 Q38335257-0BF58F0F-024C-4A4B-811B-3A744006D6CF Q40168476-DBFDC193-A8BC-44A8-B1E0-DDB13EE24906 Q40261264-5C4872E1-3C7C-44DF-8DC3-AC944D0B55B5 Q41986522-938291AA-3823-4635-8121-944D9B4539C1 Q53384832-63474747-6CD0-414C-9BE6-799B0F5F7C55

P2860

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

http://www.wikidata.org/entity/Q35518459

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@ast

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@en

type

label

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@ast

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@en

prefLabel

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@ast

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@en

P1433

Q35518459-05F54C5E-5403-4729-98E7-91E062DB2E5A

P1476

Q35518459-497F0175-21CB-47CE-B37D-81179C0FBD1F

P2093

Q35518459-7FB393BB-E286-47C8-9EFD-5E7D4BE2E2CC

Q35518459-C48C21AA-F2AB-463F-9EC9-D96A667F0B0C

Q35518459-D9B2E2FF-037D-4A70-8E04-FD6787ED8308

Q35518459-F820FCC0-50DB-4EB2-A2CC-53D3D1A90FDC

P2860

Q35518459-03EEC0FB-EB4F-44E1-9EFC-2BA50721B2CC

Q35518459-04E235AD-9C4E-4788-B7F3-1B188E47093C

Q35518459-04E584DD-5AA0-4CFC-997E-1D98935DCA4E

Q35518459-0A7684D4-B7A0-45F0-B3E5-1A4FC05DD53A

Q35518459-0CB56C9F-9D49-4AD0-BAE5-B37D071F5B32

Q35518459-17FF8763-1ACD-4C4C-AB10-CE425539B5EB

Q35518459-19ACCD0A-F88C-49A4-A72C-664D2ADE9EC7

Q35518459-1AE9EB83-C4E4-40BD-829F-77A1D74E9472

Q35518459-1CEFCAC2-C595-467F-A632-C51A4FD1BC51

Q35518459-22F55177-673F-4ED8-8842-CDF800A736C7

P304

Q35518459-EB21D3A7-CAE9-486C-BBCE-525914585BC6

P31

Q35518459-42045F2A-2D9F-4395-8D0C-997C564E1793

P356

Q35518459-E5E169F2-67D1-4D7A-9885-A0B0A0CDEEEC

P407

Q35518459-A4AF3C55-5D14-4C94-A341-87CC6514957F

P433

Q35518459-B446DB2F-9EE1-4BDE-98A6-2526EA4012D5

P478

Q35518459-279654EA-67A5-4095-9E36-F2D04CCB3DE0

P50

Q35518459-43919458-1FB0-4E96-94BE-A6D51E755E38

P577

Q35518459-8F022259-7852-4719-ADCA-83E8968CEAA5

P5875

Q35518459-56BBD391-B8D8-41F6-A9D7-335DE60524E5

P698

Q35518459-5356EC3E-5A0D-4102-9C3A-88D1099F8AA9

P921

Q35518459-8F7DDF34-6366-4827-8E37-AE850C43FEF6

Q35518459-E709C38A-B0F9-43D1-9823-FFF24355F045

P932

Q35518459-DC56FACC-2576-40D3-8CF4-D1BEA0E76ACA

P356

PNAS.1114489108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Capsular polysaccharide vaccin ...... nd Pasteurella haemolytica A2.

@en

P2093

Guilin Xie

http://www.w3.org/2001/XMLSchema#string

John B Robbins

http://www.w3.org/2001/XMLSchema#string

Lars Å Hanson

http://www.w3.org/2001/XMLSchema#string

Mark A Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Consequences of neural cell adhesion molecule deficiency on cell migration in the rostral migratory stream of the mouse

The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV

Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.

The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III

A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.

Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.

The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.

P304

17871-17875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1114489108

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Schneerson

P577

2011-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51743792

http://www.w3.org/2001/XMLSchema#string

P698

22025709

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

Neisseria meningitidis

P932

3207679

http://www.w3.org/2001/XMLSchema#string